Try our Advanced Search for more refined results
June 12, 2020
Sanofi-Aventis U.S. LLC, et al. v. Sandoz Inc.
Case Number:
1:20-cv-00804
Court:
Nature of Suit:
Patent - Abbreviated New Drug Application(ANDA)
Judge:
Firms
- Heyman Enerio
- Morris James
- Morris Nichols
- Phillips McLaughlin
- Potter Anderson
- Richards Layton
- Shaw Keller
- Smith Katzenstein
- Stamoulis & Weinblatt
Companies
- Allergan PLC
- Apotex Inc.
- Belcher Pharmaceuticals LLC
- Breckenridge Pharmaceutical Inc.
- Dr. Reddy's Laboratories Ltd.
- Fresenius Kabi AG
- Glenmark Pharmaceuticals Ltd.
- Mylan NV
- Sanofi
- Teva Pharmaceutical Industries Ltd.
Sectors & Industries:
View recent docket activity
Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.
Coverage
-
June 28, 2023
Sanofi Clears Cancer Drug From More Generic Competition
A federal judge in Delaware has come down on the side of Sanofi in the major drugmaker's efforts to assert one of the newer patents it landed on a blockbuster drug that treats prostate cancer — letting it block Novartis' generic arm from marketing its own competing drug.
Parties
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Direct access to case information and documents.
- All significant new filings across U.S. federal district courts, updated hourly on business days.
- Full-text searches on all patent complaints in federal courts.
- No-fee downloads of the complaints and so much more!
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login